is zepbound tirzepatide or semaglutide Hair loss with GLP-1 drugs rare, but real, studies find Zepbound users lost nearly 50%

Deliberately pushing that pathway harder has a theoretical cancer-risk question attached that has never been studied in humans, because dihexa has never been studied in humans at all

This CJC-1295 (no DAC) and Ipamorelin blend is studied in growth-hormone research

Ohyama M

Most patients experience steady weight gain over months, with the rate depending on individual metabolism, diet, and activity level

How GLP-1s Influence What You Smell GLP1 agonists were originally designed to regulate blood sugar and appetite in people with type 2 diabetes

Long-term cardiovascular outcomes look positive: semaglutide reduced the risk of major adverse cardiac events by 26% in patients with existing heart disease or diabetes in the SELECT trial